Mar 20, 2025
Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
Feb 18, 2025
Numinus Wellness Inc. Announces CFO Transition
Feb 14, 2025
Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries
Jan 23, 2025
Numinus Wellness Announces Corporate Update
Jan 13, 2025
Numinus Provides Bi-Weekly Update on Annual Filings
Dec 17, 2024
Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care
Dec 16, 2024
Numinus Provides Bi-Weekly Update on Annual Filings
Nov 15, 2024
Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care
Nov 15, 2024
Numinus Applies for Management Cease Trade Order
Aug 12, 2024
Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD
Jul 11, 2024
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results
Jul 10, 2024
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024
Jun 24, 2024
Numinus Wellness Announces Resignation of Director
Jun 20, 2024
Numinus Wellness Announces Strategic Acquisition of MedBright AI
Jun 07, 2024
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD
May 31, 2024
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders
May 30, 2024
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy
May 07, 2024
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
Apr 17, 2024
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003
Apr 15, 2024
Numinus Wellness Provides Corporate Update